Company Filing History:
2 out of 2 
1 out of 297 Years Active: 2014-2018
Title: Katherine M Smith: Innovator in Flavivirus Research
Introduction
Katherine M Smith is a prominent inventor based in Raleigh, NC (US). She has made significant contributions to the field of virology, particularly in the study of flaviviruses. With a total of 2 patents, her work has implications for vaccine development and viral research.
Latest Patents
Katherine's latest patents include innovative methods and compositions concerning mutant flaviviruses with host range mutations. One of her notable inventions focuses on nucleotide sequences that encode mutant flavivirus proteins. These viruses display reduced replication in mammalian cells, providing a foundation for developing flavivirus vaccine compositions. Another significant patent involves a nucleic acid molecule that encodes an infectious RNA molecule for a live viral strain of dengue virus 3 (DV3). This invention includes a nucleotide sequence with at least 99% identity to a specified sequence, enhancing the understanding of dengue virus replication.
Career Highlights
Throughout her career, Katherine has worked with various organizations, including Arbovax, Inc. and the Research Development Foundation. Her research has been pivotal in advancing the understanding of flavivirus infections and potential treatments.
Collaborations
Katherine has collaborated with notable colleagues, including Raquel Hernandez and Dennis T Brown. These partnerships have contributed to her innovative research and the development of her patents.
Conclusion
Katherine M Smith's contributions to flavivirus research highlight her role as an influential inventor in the field. Her patents not only advance scientific knowledge but also pave the way for future vaccine developments.